Clinical Trials Directory

Trials / Completed

CompletedNCT04597489

Fractional FLOw Reserve In Cardiovascular DiseAses

Status
Completed
Phase
Study type
Observational
Enrollment
64,045 (actual)
Sponsor
LinkCare GmbH · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The FLORIDA (Fractional FLOw Reserve In cardiovascular DiseAses) study sought to investigate outcomes of FFR-guided versus angiography-guided treatment strategies in a large, real-world cohort.

Detailed description

The objective of the FLORIDA study was to investigate mortality outcomes of FFR-guided versus angiography-guided treatment strategies in a large, real-world patient cohort, including patients with different stages of coronary artery disease as well as patients with acute coronary syndrome (ACS). All patients were followed for a period of 3 years after the index date. The analysis period extended from the individual index date to the date of death or the end of the 3-year follow-up period. Patients were matched for sex, presence of acute coronary syndrome, age ± 5 years, and propensity scores estimated with logistic regression based on 72 variables , with each FFR patient matched to the closest angiography-only patient

Conditions

Interventions

TypeNameDescription
PROCEDUREFractional flow reservePatients were stratified into the FFR group if a coronary angiography with adjunctive FFR measurement was performed during the index hospitalization.
PROCEDUREAngiography-onlyPatients were stratified into the angiography-only group if a coronary angiography without adjunctive FFR measurement was performed.

Timeline

Start date
2019-12-01
Primary completion
2020-01-20
Completion
2020-03-02
First posted
2020-10-22
Last updated
2020-10-22

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04597489. Inclusion in this directory is not an endorsement.